Accolade Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Selling, General & Admin	2.46	0.46	0.8	0.65	0.5
Research & Development	0.21	-	0.01	0.23	0.18
Operating Expenses	3.64	1.44	4.52	3.1	6.5
Operating Income	-3.64	-1.44	-4.52	-3.1	-6.5
Interest Expense	-	-0.04	-0.11	-0.1	-0.23
Other Non Operating Income (Expenses)	0.01	-	-	-	-0.12
EBT Excluding Unusual Items	-3.59	-1.48	-4.63	-3.2	-6.85
Merger & Restructuring Charges	-	-	-	-0.11	-
Other Unusual Items	-0.23	-0.23	-0.13	-0.12	-0.7
Pretax Income	-3.82	-1.71	-4.75	-3.44	-7.55
Net Income	-3.82	-1.71	-4.75	-3.44	-7.55
Net Income to Common	-3.82	-1.71	-4.75	-3.44	-7.55
Shares Outstanding (Basic)	20	20	29	22	7
Shares Outstanding (Diluted)	20	20	29	22	7
Shares Change (YoY)	-8.38%	-33.36%	30.39%	218.63%	-
EPS (Basic)	-0.20	-0.09	-0.16	-0.15	-1.07
EPS (Diluted)	-0.20	-0.09	-0.16	-0.15	-1.07
Free Cash Flow	-1.24	-0.87	-0.78	-0.66	-0.47
Free Cash Flow Per Share	-0.06	-0.04	-0.03	-0.03	-0.07
EBITDA	-3.64	-1.44	-4.52	-3.1	-6.5
D&A For EBITDA	0	0	0	0	0
EBIT	-3.64	-1.44	-4.52	-3.1	-6.5

Updated May 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.